Vanguard Group
ENFN

Vanguard Group’s Enfusion, Inc. ENFN Stock Holding History

Vanguard Group’s Portfolio ENFN Stock Details ENFN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-3,575,444
Closed -$39.9M – 4348
2025
Q1 		$39.9M Buy
3,575,444
+233,883
+7% +$2.59M ﹤0.01% 2186
2024
Q4 		$34.4M Sell
3,341,561
-676,290
-17% -$6.54M ﹤0.01% 2322
2024
Q3 		$38.1M Buy
4,017,851
+219,827
+6% +$1.9M ﹤0.01% 2293
2024
Q2 		$32.4M Buy
3,798,024
+144,835
+4% +$1.33M ﹤0.01% 2330
2024
Q1 		$33.8M Buy
3,653,189
+51,670
+1% +$455K ﹤0.01% 2337
2023
Q4 		$34.9M Buy
3,601,519
+113,704
+3% +$1.06M ﹤0.01% 2338
2023
Q3 		$31.3M Buy
3,487,815
+512,479
+17% +$4.87M ﹤0.01% 2355
2023
Q2 		$33.4M Buy
2,975,336
+1,297,744
+77% +$11.5M ﹤0.01% 2367
2023
Q1 		$17.6M Sell
1,677,592
-516,864
-24% -$5.7M ﹤0.01% 2642
2022
Q4 		$21.2M Buy
2,194,456
+670,175
+44% +$7.55M ﹤0.01% 2597
2022
Q3 		$18.8M Buy
1,524,281
+115,925
+8% +$1.41M ﹤0.01% 2652
2022
Q2 		$14.4M Sell
1,408,356
-323,563
-19% -$3.58M ﹤0.01% 2804
2022
Q1 		$22M Sell
1,731,919
-1,929
-0.1% -$29.5K ﹤0.01% 2710
2021
Q4 		$36.3M Buy
+1,733,848
New +$35M ﹤0.01% 2526

Other funds holding ENFN

N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Vanguard Group's ENFN Position: Q2 2025 in Review

Vanguard Group sold out of Enfusion, Inc. (ENFN) in Q2 2025, closing a stake of 3,575,444 shares — an estimated $39.9M sold.

Vanguard Group first reported a position in ENFN in Q4 2021 and held it in 14 quarters. The position peaked at $39.9M in Q1 2025. 2 funds tracked by Wall St. Rank hold ENFN as of Q2 2025.

  • Vanguard Group reported no remaining Enfusion, Inc. position as of Q2 2025 after selling out during the quarter.
  • Vanguard Group sold 3,575,444 Enfusion, Inc. shares in Q2 2025, an estimated $39.9M.
  • Vanguard Group first reported a position in Enfusion, Inc. in Q4 2021 and held it in 14 quarters.
  • Vanguard Group's Enfusion, Inc. position peaked at $39.9M in Q1 2025.
  • 2 funds tracked by Wall St. Rank held Enfusion, Inc. as of Q2 2025.

Based on Vanguard Group's 13F filing for Q2 2025, filed 11 Aug 2025.